A Digital Ergonomics Assessment of Work-related Musculoskeletal Disorders Risk Between Female and Male Physical Therapists. (MD)

May 14, 2026 updated by: alaa mohamed ibrahim hashem, Cairo University
this study will be conducted to investigate the risk of work-related musculoskeletal disorders due to the postural load between female and male physical therapists by utilization of digital ergonomics analysis.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Musculoskeletal disorders (MSDs) refer to an array of signs and symptoms involving various areas of the musculoskeletal system. The clinical manifestations of MSDs include pain, swelling/redness, stiffness, and weakness or loss of function. Such manifestations affect the muscles, joints, tendons, nerves, and supporting structures in various body parts. Work-related musculoskeletal disorders (WMSDs) have a high significant occupation problem worldwide.The prevalence of WRMDs among Egyptian physiotherapists is high. Physical therapist often initiate their clinical careers with prolonged exposure to physically demanding tasks, such as working with patients in various body positions. This early exposure can establish lifelong patterns of movement and posture that increase the risk of developing work-related musculoskeletal disorders (WRMDs). By identifying and addressing potential ergonomic risk between genders during this formative period, we aim to prevent the onset of WRMDs and promote long-term occupational health among physical therapists. This study will focus on assessing the prevalence of poor body mechanics and identifying the risk of WRMDs between female and male physical therapists in their early clinical careers.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
217

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

A two hundred and seventeen of Egyptian physical therapists . They will be selected from Al Kasr Elaini Hospital and at the outpatient clinics of the Faculty of Physical Therapy at Cairo and Badr University. Their age is 21-30 years old of physical therapist and their BMI is between 18 and 24.9. needed to capture videos from a lateral view for Kinovea analysis of the angles and degrees of sagittal plane motion (for shoulder , elbow, wrist, neck and trunk joints ) and from an anterior view to determine the presence of frontal plane motion (in shoulder, elbow, wrist, neck and trunk joints) to fulfill the RULA to estimate the Risk of work-related musculoskeletal disorder .

Description

Inclusion Criteria:

  • Males and females Egyptian physical therapists at Al Kasr Elaini Hospital and at the outpatient clinics of the Faculty of Physical Therapy, Cairo University, and Badr university, will be included in the study.
  • Age ranges from 21-30 years old of physical therapists and their BMI is between 18 and 24.9.
  • 4 hours of work daily at least
  • No working experience to 2 years of experience only

Exclusion Criteria:

  • Congenital musculoskeletal disorders
  • Page 3 of 4 [DRAFT] -
  • Fractures
  • Previous musculoskeletal surgery
  • Cardiovascular disease
  • Pulmonary disease
  • Diabetes
  • Neurological disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
female physical therapists
Work-related Musculoskeletal Disorders Risk Among female Physical Therapists The study will be carried out on 109 of Egyptian physical therapists female . They will be randomly selected from Al Kasr Elaini Hospital and at the outpatient clinics of the Faculty of Physical Therapy at Cairo and Badr University.
Other: female physical therapists
109 female physical therapists under Work-related Musculoskeletal Disorders Risk Among Physical Therapist will be included in the study.
male physical therapists

Work-related Musculoskeletal Disorders Risk Among male Physical Therapists The study will be carried out on 108 of Egyptian physical therapists who are male.

They will be randomly selected from Al Kasr Elaini Hospital and at the outpatient clinics of the Faculty of Physical Therapy at Cairo and Badr University.
Other: male physical therapists
108 male physical therapists under Work-related Musculoskeletal Disorders Risk Among Physical Therapist will be included in the study.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
range of motion
Time Frame: up to one day
kinovea soft wear will be used to measure joints range of motions.this will be applied through Capturing videos by iPhone 11 from lateral view for kinovea analysis the angles degrees of sagittal plane motion (for shoulder , elbow, wrist, neck and trunk joints ) and from anterior view to determined the presence of frontal plane motion (in shoulder, elbow, wrist, neck and trunk joints)
up to one day
postural load
Time Frame: up to one day
The rapid upper limb assessment (RULA) will be used to assess the postural load and to know if physical therapy interns are exposed to MSD risk factors during the performance of their work
up to one day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
May 30, 2026

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
September 1, 2026

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
September 1, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
May 14, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 14, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
May 20, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
May 20, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 14, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
May 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • IRB00014233-78

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Musculoskeletal Disorder

Clinical Trials on female physical therapists

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings